Shanghai Shyndec Pharmaceutical (600420.SH): Injection cephalosporin sodium is evaluated through consistency evaluation.
China National Pharmaceutical Group (600420.SH) announced that its subsidiary, Shantou Jinshi Powder Injection Co., Ltd. (referred to as China National Pharmaceutical...
Shanghai Shyndec Pharmaceutical (600420.SH) announced that its controlling subsidiary, Shantou Jinshi Powder Injection Co., Ltd. (referred to as Guoyao Jinshi Powder Injection), has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration, approving the injection of Ceftereetonate Sodium (0.5g) through a generic drug quality and efficacy consistency evaluation.
Related Articles
China Securities Co., Ltd.: Investment Outlook for the Vaccine Industry in 2026
What reasons could potentially cause the unexpected appreciation of the US dollar next year in 2026? Pay attention to the possibility of a phase reversal in the economic rhythm in the third and fourth quarters.
"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"
China Securities Co., Ltd.: Investment Outlook for the Vaccine Industry in 2026
What reasons could potentially cause the unexpected appreciation of the US dollar next year in 2026? Pay attention to the possibility of a phase reversal in the economic rhythm in the third and fourth quarters.
"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
